Please provide your email address to receive an email when new articles are posted on . Smilowitz and Berger reviewed studies published between January 1, 1949 and January 27, 2020 to find available ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio On March 28 and 29, the FDA ...

The risk and impact of cardiovascular (CV) adverse events (AEs) in long-term users of tyrosine kinase inhibitors (TKIs) for chronic myeloid leukaemia (CML) is highlighted in a review published in the ...

Adults who survived childhood cancer don’t get any added benefit from tailored counseling beyond what’s achieved with standard CV risk assessments, new data from a randomized clinical trial suggest.

A paradigm of the metabolic syndrome in the general population is shown in Figure 1. In conclusion, in studies on the cluster of metabolic syndrome CV risk factors in non-RA subjects, many ...